PERCEPT™ PC NEUROSTIMULATOR Neurostimulator for Deep Brain Stimulation Therapy
The first complete DBS system with sensing, directionality, and visual programming giving you access to the personalised data-driven insights you need to make informed decisions.
CONTACT US
Overview
PRODUCT DETAILS
Unprecedented Insights — Inside and Outside of the Clinic
Personalise DBS therapy for your patients using objective data combined with event capturing.
The Percept™ PC device features BrainSense™ technology designed to capture brain signals (local field potential, or LFP) using the implanted DBS lead. These signals can be recorded simultaneously while delivering therapeutic stimulation, inside and outside the clinic.† BrainSense™ technology delivers personalised insights into patient's symptom fluctuations which could help maximize ON-time.1-4
You can correlate these brain signals with stimulation and events capturing medication, symptoms, or side effects — to deliver personalized, data-driven treatment and adjust as patients' needs evolve.‡
Read about research on brain sensing and BrainSense™ technology in this scientific compendium.
Empower Your Patients
Easy-to-Adjust Stimulation Options
The DBS patient programmer is enhanced so patients can more easily and conveniently engage with their therapy.
Assign custom names to therapy groups so that patients can easily adjust and customize their therapy to their desired activities.
Digital Diary
Configure up to four custom events — such as medication adherence, side effects, and experiencing on/off state — that your patients can track digitally using the intuitive patient programmer.
The only 1.5T and 3T MR Conditional DBS System
The Percept™ PC device adds full-body 3T MRI eligibility§ for DBS patients, so they may benefit from the cutting-edge medical imaging when they need it. Plus, using a bipolar therapy group allows therapy to be ON during an MRI scan.5
Now clinicians can use MRI Eligibility workflow on the clinician programmer to check MRI eligibility, generate an eligibility report, and place a patient’s device into the appropriate state for an MRI exam.
Patients can use MRI Mode on their patient programmer for a streamlined path to conditionally safe MRI scans, without needing to visit the clinician managing their DBS therapy.
Expanded Access to MRI
The expanded MRI eligibility of the Percept™ PC device supports the most prevalent and fastest-growing MRI modalities.6
Estimated Global MRI Systems Market:
Engineered for Patient Comfort
Modern and Ergonomic
Percept™ PC device is smaller and thinner than the previous generation Activa™ PC device, and features a modern, ergonomic design — offering enhanced comfort for patients.7
Designed to Last Longer — and Keep You Informed
Percept™ PC device is smaller|| yet offers improved longevity.
Plus, its smart battery technology provides real-time prediction of remaining battery life,** so you and your patients can have elevated peace of mind when planning for a replacement device.
Smart, Personalised and Future-ready Technology3
The Percept™ PC device features our most advanced DBS technologies: proprietary cortex chipset, custom cutting-edge electronics, and embedded software for patented processing and analysis of brain signals.
The state-of-the-art Percept™ PC device is also designed to facilitate expanded capabilities in the future via software upgrades — so you’re prepared for what’s next in DBS.4
PRODUCT SPECIFICATIONS
Compatible with:
- Lead model 3387 – movement disorders and epilepsy
- Lead model 3389 – movement disorders
- Extension model 37086
- Clinician programmer model CT900 (tablet) with clinician programmer software application A610, and communicator model 8880T2
- DBS Patient Programmer Model TH91D with patient programmer software application A620
Model Specifications
| Model | B35200 |
|---|---|
| Battery | Primary Cell |
| Weight | 61g |
| Height | 68mm |
| Length | 51mm |
| Channels | 2 |
PRODUCT SUPPORT
Call UK Technical Services & Mobility Support +44 1923 201 805
*
Medtronic's Activa™ PC+S device received CE Mark on January 17, 2013, but was not commercially distributed.
†
Signals may not be present or measurable in all patients.
‡
Clinical benefits of brain sensing have not been established.
§
Medtronic DBS systems are MR Conditional which means they are safe for MRI scans only under certain conditions. If the conditions are not met, the MRI could cause tissue heating, especially at the implanted lead(s) in the brain, which may result in serious and permanent injury or death. Before having an MRI, always talk with the doctor who manages your DBS Therapy to determine your eligibility and discuss potential benefits and risks of MRI. For further information, please call Medtronic at +44 (0) 1923 205101.
||
In overall device volume
¶
Refers to case thickness
#
Based on current actual battery level and therapy settings from last seven days.
**
For median energy use in DBS for patients with Parkinson’s disease, with moderate (up to 2 months per year) BrainSense™ technology usage
††
For median energy use in DBS for patients with Parkinson’s disease, with equivalent settings and no BrainSense™ technology usage
1
Feldmann LK, Lofredi R, Neumann WJ, et al. Toward therapeutic electrophysiology: beta-band suppression as a biomarker in chronic local field potential recordings. NPJ Parkinsons Dis. 2022. Apr 19;8(1):44.
2
Feldmann LK, Neumann WJ, Krause P, et al. Subthalamic beta band suppression reflects effective neuromodulation in chronic recordings. Eur J Neurol. 2021. Jul;28(7):2372-2377.
3
Cummins DD, Kochanski RB, Gilron R, et al. Chronic Sensing of Subthalamic Local Field Potentials: Comparison of First and Second Generation Implantable Bidirectional Systems Within a Single Subject. Front Neurosci. 2021. Aug 10;15:725797.
4
Thenaisie Y, Palmisano C, Canessa A, et al. Towards adaptive deep brain stimulation: clinical and technical notes on a novel commercial device for chronic brain sensing. J Neural Eng. 2021;18(4):10.1088/1741-2552/ac1d5b. Published 2021 Aug 31. doi:10.1088/1741-2552/ac1d5
5
MRI guidelines for Medtronic deep brain stimulation systems 37601 37602 37603 37612 B35200 —M929535A074 Rev B, accessed on May 27, 2022.
6
BCC Research Report HLC078D: Medical Magnetic Resonance Imaging (MRI) Technologies and Global Markets (July 2018).
7
NDHF1550-188790 Percept PC (model B35200) INS Dimensional Analysis Report, v2.
Brief Statement:
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at www.medtronic.eu.
For applicable products, consult instructions for use on manuals.medtronic.com. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.